Nektar Therapeutics NKTR Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's total costs & expenses?
- Nektar Therapeutics (NKTR) reported total costs & expenses of $49.92M in Q1 2026.
- How has Nektar Therapeutics's total costs & expenses changed year-over-year?
- Nektar Therapeutics's total costs & expenses decreased by 9.2% year-over-year, from $55M to $49.92M.
- What is the long-term trend for Nektar Therapeutics's total costs & expenses?
- Over 4 years (2021 to 2025), Nektar Therapeutics's total costs & expenses has grown at a -22.7% compound annual growth rate (CAGR), from $548.01M to $195.33M.
- What does total costs & expenses mean?
- This metric aggregates all operating costs, including research and development, selling, general, and administrative expenses, and other production-related outlays. It provides a comprehensive view of the total capital required to sustain the company's current business activities and pipeline development. Monitoring this figure helps assess the company's overall cost structure and operational efficiency relative to its revenue generation.